Shulou(Shulou.com)11/24 Report--

CTOnews.com May 28 news, in the ongoing Zhongguancun Forum exhibition, a domestic interventional surgery robot attracted a lot of attention. The robot, the first fully independently developed product through the "green channel" of the State Drug Administration, has successfully completed the first PCI (percutaneous coronary intervention) surgery at Beijing Anzhen Hospital and is expected to be commercialized in the second half of this year or early next year.

The robot, developed by Weimai Medical, is an "eye-hand-brain" integrated surgery platform for collaborative intervention, which is composed of a medical angiography X-ray machine, an interventional surgery robot and an AI (artificial intelligence) system. Medical angiography X-ray machine can clearly show the vascular condition of patients, interventional surgery robot can replace the hands of doctors to carry out various surgical operations, AI system can provide doctors with the best surgical treatment according to the experience and knowledge of domestic experts.

The advantage of this robot is that it can operate remotely, so that patients in grass-roots hospitals or areas where medical resources are scarce can be treated in a timely manner. At the same time, the robot can also improve the accuracy and efficiency of surgery, reduce the risk of complications of patients, and shorten the training cycle of interventional doctors. In addition, CTOnews.com noted that it can also protect the health of medical staff and avoid occupational injuries caused by X-ray radiation in traditional interventional surgery.

Welcome to subscribe "Shulou Technology Information " to get latest news, interesting things and hot topics in the IT industry, and controls the hottest and latest Internet news, technology news and IT industry trends.